Substituted imidazoles as bombesin receptor subtype-3...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/10 (2006.01) A61K 31/4178 (2006.01) A61K 31/4439 (2006.01) A61P 3/10 (2006.01) C07D 403/10 (2006.01)

Patent

CA 2664794

Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.

L'invention concerne certains nouveaux imidazoles substitués qui sont des ligands du récepteur de la bombésine humaine et, en particulier, des ligands sélectifs du sous-type 3 du récepteur de la bombésine humain (BRS-3). Lesdits imidazoles substitués sont utiles dans le traitement, le contrôle et la prévention de maladies et de troubles réagissant à la modulation du BRS-3, comme l'obésité et le diabète.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted imidazoles as bombesin receptor subtype-3... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted imidazoles as bombesin receptor subtype-3..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazoles as bombesin receptor subtype-3... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1629502

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.